Research has shown that ADAR1 can be both beneficial and a hindrance in a cells ability to fight off HIV infection.
Studies of samples from patients with hepatocellular carcinoma (HCC) have shown that ADAR1 is frequently upregulated and ADAR2 is frequently downregulated in the disease.